CGC (51) OBIO (28) USNA (61) TLRY (32) ⌘ Pro Terminal →

SNDL Inc. (SNDL) — RQD Stock Rating Cockpit

$1.30 +0.78% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.30

SNDL Inc. (SNDL) carries a Roarable Rating of C- (Hold) with 61/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

📊 Historical Track Record: Scores of 61/100 (C-) historically posted market-perform odds over rolling 90-day windows (+0.5% avg 90D alpha vs SPY) →

ROARABLE C- • HOLD / WATCH Cap $316.3M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $1.30 (-0.05%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 0.2% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 61/100 (C-) historically posted market-perform odds over rolling 90-day windows (+0.5% avg 90D alpha vs SPY • 53.9% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERHOLD / WATCH • C-

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk B-

Each axis scored 0–20

12M PRICE TARGET CONE+1.5% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for SNDL)Realized 20D OHLCV Swing Band: ±8.5%

Deterministic 5-Pillar Attribution (61/100 Composite)

🔍 WHY SNDL SCORES 61/100 (C-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Macro Regime Fit+15/20 pts (25% of score)

FRED Regime × Technicals: 14% of 52W Range • RSI-14 at 43.6 (NEUTRAL RANGE)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (21% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution9/20 pts (-11 pt drag)

Disciplined Float (-0.40% YoY Shares) & executive Form 4 sales trim 11 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C-$1.22+2.5% Next Q

Q2 (-2Q)

Grade C$1.25+3.2% Next Q

Q3 (-1Q)

Grade C$1.29+0.8% Next Q

Current

Grade C-$1.30+0.5% Hist 90D α

Trajectory: C- (53) → C- (61)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the SNDL Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 61/100 (C-) score, SNDL faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Company executives have done more routine share selling than personal cash buying lately.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Disciplined Float (-0.40% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($1.32) or 200D SMA ($1.39) invalidates the momentum regime and cuts Target Base ($1.32) toward Bear Floor ($1.03).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $SNDL• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “SNDL Beats Next Quarter EPS Consensus (Upcoming Quarter) & Holds Above 200D SMA”

YES 61%NO 39%Trade / Inspect Odds →

RSI-14 MOMENTUMNEUTRAL RANGE

43.630 Oversold · 70 Hot

ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)

3.80>3.0 Fortress Safe

PIOTROSKI F-SCOREHIGH QUALITY (7–9)

7 / 99-Pt Accounting

52-WEEK LASER RANGE14% OF RANGE

L: $1$1.30H: $2

1. Money & Cash Health● MIXED

Are profits real cash in the bank?

Decent core business (steady margins), though cash flow growth is moderate rather than explosive right now.

Factor Grade: C-RQD 12 / 20

2. Big Money & Insiders● TRIMMING

Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: D+RQD 21 / 40

3. Hidden Risks & Market Weather● ALL CLEAR

SEC fine-print scan & interest-rate fit

Clean SEC fine-print check with low hidden accounting risk and favorable interest-rate weather.

Factor Grade: B-RQD 28 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

JEV AI Jury Split (Battleground) on SNDL

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

NEUTRAL (60)

14.0% ROIC with 42.0% gross margin and 2.80% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

NEUTRAL (65)

Altman-Z 4.20 and Piotroski 7/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

NEUTRAL (60)

21/40 institutional & smart-money positioning score with 15/20 macro alignment.

Bull Case: Why Buyers Like SNDL

✓Established market leader in Health Care with deep daily trading liquidity.

Bear Case: What Could Go Wrong

!Company executives have done more routine share selling than personal cash buying lately.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (SNDL Tape Review)

✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
✓Forensic Red-Light accounting & dilution traps to review on your watchlist
✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

SNDL // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -4.41%▼ DESCENDING CHANNEL

2026-10-30O $1.29H $1.30L $1.24C $1.30VOL 1.38M

RES: $1.44SUP: $1.12SMA50: $1.32SMA200: $1.39

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

SNDL Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 SNDL Butterfly Map → + Track SNDL →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on SNDL today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for SNDL. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for SNDL today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (SNDL)

Health Care Rank #192 of 1016 ⚔️ CGC vs SNDL Full Matrix →

1. Head-to-Head Health Care Peer Comparison (SNDL vs. CGC, OBIO, USNA, TLRY)

Industry: Medicinal Chemicals and Botanical Products (24 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, SNDL Inc. (SNDL) ranks #192 by composite RQD confidence (61/100, grade C-) and #515 by equity capitalization ($316.3M). Within this direct 5-issuer industry benchmark cohort, USNA leads on earnings valuation at 24.6x trailing P/E, while USNA leads on capital efficiency and profitability with 7.9% ROIC and 78.3% gross margin. SNDL currently leads its immediate peer cohort in composite quantitative strength at 61/100 (C-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
SNDL ACTIVE SNDL Inc.	C-	61/100	—	—	—	+0.78%	$316.3M	Benchmark Subject
CGC Canopy Growth Corporation	D	51/100	—	—	—	+0.46%	$285.6M	/cgc-vs-sndl →
OBIO Orchestra BioMed Holdings Inc.	E	28/100	—	96.0%	-35.0%	+1.67%	$366.0M	/obio-vs-sndl →
USNA USANA Health Sciences Inc.	C-	61/100	24.6x	78.3%	7.9%	-1.91%	$265.0M	/usna-vs-sndl →
TLRY Tilray Brands Inc.	E	32/100	—	28.4%	-3.9%	-1.86%	$390.2M	/tlry-vs-sndl →

2. SNDL Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

SNDL Inc. (SNDL) operates in Medicinal Chemicals and Botanical Products (Health Care) with an equity capitalization of $316.3M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.

3. SNDL Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is SNDL stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, SNDL Inc. (NASDAQ: SNDL) is rated C- (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 61/100 at a spot price of $1.30 (+0.78% 1D, market cap $316.3M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, SNDL ranks #192 in composite RQD confidence.

How does SNDL compare to CGC and OBIO in the Health Care sector?

Within the Health Care sector (Medicinal Chemicals and Botanical Products), SNDL carries a Roarable C- (61/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, CGC (Canopy Growth Corporation) holds a D grade (51/100 RQD, P/E N/A, ROIC —, cap $285.6M) and OBIO (Orchestra BioMed Holdings Inc.) posts a E grade (28/100 RQD, P/E N/A, ROIC -35.0%, cap $366.0M). Among the 5-stock peer group, USNA leads on earnings multiple (24.6x) while USNA leads on capital efficiency (7.9% ROIC).

What are the biggest fundamental strengths and SEC risk factors for SNDL?

For SNDL Inc. (SNDL), key quantitative strengths include Established market leader in Health Care with deep daily trading liquidity. and sector rank #192 in Health Care, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and implied 5-year growth hurdle of 8.0%/yr. Institutional options positioning shows a 50% call / 50% put premium split.

Where is SNDL trading relative to its 50-day, 200-day, and 52-week technical levels?

SNDL last traded at $1.30 (+0.78% on volume of 1,082,601 shares), positioning the stock -1.52% below its 50-day simple moving average ($1.32) and -6.47% below its 200-day simple moving average ($1.39). Across its 52-week range of $1.13 to $2.34, SNDL sits at the 14.0% percentile with a 14-day RSI of 43.6 (NEUTRAL RANGE) and an implied next-earnings move of ±8.5% ($1.19 to $1.41).

SNDL Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell SNDL stock right now?

SNDL Inc. (SNDL) currently earns a Roarable Rating of C- (Hold — HOLD) with 61/100 RQD Confidence. Solid steady margins (steady margins), mixed timing at current multiples—hold if owned, no rush to chase.

What is SNDL's 12-month price target and RQD AI Jury consensus?

SNDL's 12-month base price target is $1.32 (range $1.03 to $2.46), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Direct Sub-Reports: SNDL RQD Cockpit SNDL 12M Forecast SNDL Earnings & Move SNDL Dividends & DRIP SNDL Insiders & 13F SNDL Whale Options SNDL Profit Sankey SNDL News & Why